Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
AbbVie (NY: ABBV)
79.76 USD  -1.48 (-1.82%)
Official Closing Price  /  Updated: 7:44 PM EDT, Mar 22, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 4,992,800
Open 80.78
Bid (Size) 79.29 (3)
Ask (Size) 80.05 (1)
Prev. Close 81.24
Today's Range 79.69 - 81.99
52wk Range 75.77 - 113.79
Shares Outstanding 1,586,879,451
Dividend Yield 4.50%
Performance
YTD
-10.61%
-10.61%
1 Month
-0.94%
-0.94%
3 Month
-6.57%
-6.57%
6 Month
-13.94%
-13.94%
1 Year
-29.07%
-29.07%
Top News
More News
AbbVie Provides Update on VENCLEXTA®/VENCLYXTO® (venetoclax) Multiple Myeloma Program
AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced the U.S. Food and Drug Administration (FDA) has placed a partial clinical hold on all clinical trials evaluating... Read More
from PR Newswire
AbbVie Announces Multiple Milestones for Phase 3 CLL14 Venetoclax Study of Fixed Duration Treatment in Previously-Untreated Chronic Lymphocytic Leukemia Patients
- The Phase 3 CLL14 trial of venetoclax in combination with obinutuzumab is the first randomized clinical trial to examine a chemotherapy-free treatment given for a fixed duration in... Read More
from PR Newswire
More News
Read More
UPDATE 1-FDA puts partial hold on clinical trials of AbbVie's cancer drug
category companyNews
from Reuters: Company News
FDA puts partial hold on clinical trials of AbbVie's cancer drug
category companyNews
from Reuters: Company News
Better Buy: AbbVie vs. Eli Lilly
category LLY , Market News , ABBV
from Motley Fool
Undervalued Growth and Dividend Growth in Health Technology
category Healthcare , Stocks / Equities
from Blogs - TalkMarkets
IWV, UNH, ABBV, HON: Large Inflows Detected at ETF
category ETFs
from ETF Channel
Look Under The Hood: XLV Has 11% Upside
category ETFs
from ETF Channel
Performance Of The Top 10 Dividend Aristocrats 2019
category Stocks / Equities
from Blogs - TalkMarkets
2 Things Investors Are Missing About AbbVie
category Market News , ABBV
from Motley Fool
Senate panel asks CVS and four other pharmacy middlemen to testify about drug prices
category People/Newsmakers/Donald Trump , Medical biotechnology industry , Biotechnology , and 20 more.
from CNBC.com News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.